Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · Real-Time Price · USD
1.200
0.00 (0.00%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Actinium Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
3739139271132106
Upgrade
Market Cap Growth
-2.51%-71.78%-48.69%104.97%24.94%195.56%
Upgrade
Enterprise Value
-15-38581625159
Upgrade
Last Close Price
1.201.265.0810.656.017.80
Upgrade
PS Ratio
414.21-1719.26263.49115.74-
Upgrade
PB Ratio
2.721.203.834.081.801.73
Upgrade
P/TBV Ratio
2.701.203.834.081.801.73
Upgrade
P/FCF Ratio
---32.78--
Upgrade
P/OCF Ratio
---31.40--
Upgrade
EV/Sales Ratio
--722.14157.4644.40-
Upgrade
EV/FCF Ratio
---19.59--
Upgrade
Debt / Equity Ratio
0.080.050.060.040.000.01
Upgrade
Debt / FCF Ratio
---0.31--
Upgrade
Net Debt / Equity Ratio
-3.79-2.18-2.05-1.60-1.05-1.02
Upgrade
Net Debt / EBITDA Ratio
1.411.701.443.143.132.82
Upgrade
Net Debt / FCF Ratio
2.092.161.57-12.843.692.87
Upgrade
Asset Turnover
0.00-0.000.010.02-
Upgrade
Quick Ratio
7.818.959.0310.2511.3813.33
Upgrade
Current Ratio
7.969.149.2110.4411.6613.62
Upgrade
Return on Equity (ROE)
-133.09%-110.63%-94.92%-47.16%-36.74%-66.35%
Upgrade
Return on Assets (ROA)
-33.76%-33.25%-33.17%-21.91%-21.26%-35.85%
Upgrade
Return on Capital Employed (ROCE)
-75.70%-61.30%-71.20%-32.90%-33.90%-36.30%
Upgrade
Earnings Yield
-92.81%-97.29%-35.05%-12.17%-18.71%-20.96%
Upgrade
FCF Yield
-67.17%-84.17%-34.10%3.05%-15.86%-20.64%
Upgrade
Buyback Yield / Dilution
-7.11%-13.03%-10.20%-17.37%-69.51%-143.87%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.